Intravitreal Bevacizumab for Age-Related Macular Degeneration

Sponsor
Asociación para Evitar la Ceguera en México
Study ID
NCT00347165
Phase
PHASE2
Status
Terminated

Conditions

  • Age Related Macular Degeneration

Eligibility Criteria

Sex
ALL
Age
50 Years - 99 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to determine whether intravitreal injection of bevacizumab is effective in the treatment of neovascular age related macular degeneration

Key Dates

First listed
Jul 4, 2006
Start date
Sep 30, 2005
Status verified
May 2024
Primary completion
Jun 30, 2006
Completion
Sep 30, 2006

Study Design

Enrollment
50 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Improvement of visual acuity at 6 months

Related Studies